The primary goal of development at Sosei is to test rapidly a product's proof-of-principle in a new indication and then to move it through full regulatory development. Sosei has built up an experienced medical, development and regulatory team in both Japan and Europe which is supplemented by a network of collaborators. This team has enabled the Group to implement an innovative clinical trials strategy for each product in its pipeline and efficiently gain the regulatory approvals required to progress them on an international basis.